Position in ARWR
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$663,409
+$117,669 QoQ
Shares Held
8,139
-6.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#278
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $55,990,065 across 216 Biotechnology names. ARWR ranks #10 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
62,273 | $15,242,562 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
209,318 | $11,499,930 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
34,193 | $8,239,487 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
361,634 | $6,136,928 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
61,616 | $2,403,640 | |
| 6 | EXEL |
Exelixis, Inc.
|
43,101 | $2,345,125 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,968 | $1,474,294 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,352 | $843,026 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $663,409 | 8,139 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $545,740 | 8,704 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $577,792 | 8,703 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $521,454 | 15,119 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $234,882 | 14,866 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $201,457 | 15,813 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $390,438 | 20,768 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $436,076 | 22,513 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $650,087 | 25,013 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $715,371 | 25,013 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $805,177 | 26,313 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $707,030 | 26,313 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $816,685 | 22,902 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $676,986 | 26,653 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $330 | 29,417 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $811,708 | 24,560 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $837,610 | 23,789 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $989,658 | 21,519 | Shares | Sole | 2022-08-08 | |
| 2021-12-31 | $1,424,256 | 21,482 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $1,336,751 | 21,412 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $1,730,523 | 20,895 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $1,226,933 | 18,503 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $1,427,024 | 18,598 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $840,617 | 19,522 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $802,858 | 18,589 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $495,045 | 17,207 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||